Home > Insider Trading > Filing (0001140361-10-039157)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885988	Integramed America Inc	INMD	Services-Offices & Clinics Of Doctors Of Medicine (8011)	061150326

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1311443	Blueline Partners, L.l.c.	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No
1338149	Blueline Capital Partners, L.p.	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No
1411986	Blueline Capital Partners Iii, Lp	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No
1411987	Blueline Partners Ii, Llc	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No
1453017	Blue Tsv I, Ltd.	C/O Maples Corporate Services Limited Po Box 309, Ugland House Grand Cayman E9 KY1-1104	No	No	Yes	No
1460518	Blueline Catalyst Fund Ix, L.p.	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No
1460781	Blueline Capital Partners Ii, L.p.	319 Diablo Road Ste 200 Danville CA 94526	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-09-27	5,058	$9.02	1,285,567	No	4	P	Direct
Common Stock	Acquisiton	2010-09-28	1,500	$9.09	1,289,067	No	4	P	Direct
Common Stock	Acquisiton	2010-09-30	5,802	$9.27	1,294,869	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

These securities are owned by BlueLine Capital Partners III, L.P.
These securities are owned by BlueLine Catalyst Fund IX, L.P.,As described in the Schedule 13D filing made on January 2, 2009 with respect to the Common Stock owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., BlueLine Partners II, L.L.C., and Blue TSV I, LTD, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.